Cancer risk in systemic lupus: an updated international multi-centre cohort study.

[1]  C. Mok,et al.  Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study , 2012, Annals of the rheumatic diseases.

[2]  T. Cheetham,et al.  Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine , 2012, Journal of internal medicine.

[3]  I. Lundberg,et al.  Expression of APRIL in Diffuse Large B Cell Lymphomas from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis , 2011, The Journal of Rheumatology.

[4]  H. Na,et al.  Effects of physical activity on cancer prevention , 2011, Annals of the New York Academy of Sciences.

[5]  D. Isenberg,et al.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma , 2011, Nature Reviews Rheumatology.

[6]  W. Foulkes,et al.  Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis , 2011, British Journal of Cancer.

[7]  C. Malchoff,et al.  Autoimmune thyroid disease: a risk factor for thyroid cancer. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  S. Bombardieri,et al.  Prevalence of thyroid dysfunctions in systemic lupus erythematosus. , 2010, Metabolism: clinical and experimental.

[9]  J. Strobl,et al.  Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells , 2009, Anti-cancer drugs.

[10]  A. Rosenwald,et al.  Molecular pathogenesis of follicular lymphoma , 2008, Haematologica.

[11]  R. Amaravadi.  Autophagy-induced tumor dormancy in ovarian cancer. , 2008, The Journal of clinical investigation.

[12]  M. Hochberg,et al.  A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis , 2008, Arthritis research & therapy.

[13]  F. Skopouli,et al.  Clinical, Immunologic, and Molecular Factors Predicting Lymphoma Development in Sjogren’s Syndrome Patients , 2007, Clinical reviews in allergy & immunology.

[14]  M. Urowitz,et al.  The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study , 2007, Annals of the rheumatic diseases.

[15]  D. Gladman,et al.  Lung cancer in systemic lupus erythematosus. , 2007, Lung cancer.

[16]  G. Ruiz-Irastorza,et al.  Antimalarials may influence the risk of malignancy in systemic lupus erythematosus , 2007, Annals of the rheumatic diseases.

[17]  E. Zintzaras,et al.  The risk of lymphoma development in autoimmune diseases: a meta-analysis. , 2005, Archives of internal medicine.

[18]  D. Gladman,et al.  Race/ethnicity and cancer occurrence in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[19]  D. Gladman,et al.  Non-Hodgkin’s lymphoma in systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.

[20]  D. Gladman,et al.  An international cohort study of cancer in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[21]  J. Boivin,et al.  Breast cancer stage at time of detection in women with systemic lupus erythematosus , 2004, Lupus.

[22]  J. Boivin,et al.  Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. , 2002, Journal of Rheumatology.

[23]  R. Shore,et al.  Aspirin and lung cancer in women , 2002, British Journal of Cancer.

[24]  D. Gladman,et al.  Malignancy in systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[25]  A. Zauber,et al.  Incidence of second cancers in patients treated for Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[26]  E. Pukkala,et al.  Increased risk of cancer in patients with systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.

[27]  M. Urowitz,et al.  Mortality in systemic lupus erythematosus. , 1987, Arthritis and rheumatism.

[28]  R. Hoover,et al.  Increased risk of lymphoma in sicca syndrome. , 1978, Annals of internal medicine.

[29]  S. Bombardieri,et al.  Thyroid cancer in systemic lupus erythematosus: a case-control study. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  C. Pineau,et al.  Cancer screening in patients with systemic lupus erythematosus. , 2006, The Journal of rheumatology.

[31]  Edgar M Moran,et al.  Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. , 2002, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.